Total Payments
$1,757
2024 Payments
$689.88
Companies
19
Transactions
100
Medicare Patients
72
Medicare Billing
$10,319
Payment Breakdown by Category
Food & Beverage$1,747 (99.4%)
Education$10.28 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,747 | 99 | 99.4% |
| Education | $10.28 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $335.86 | 16 | $0 (2024) |
| QOL Medical, LLC | $320.00 | 19 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $247.19 | 22 | $0 (2024) |
| Boston Scientific Corporation | $198.23 | 4 | $0 (2023) |
| ABBVIE INC. | $163.31 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $114.27 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $88.09 | 6 | $0 (2024) |
| RedHill Biopharma Inc. | $62.64 | 4 | $0 (2023) |
| Olympus America Inc. | $36.20 | 1 | $0 (2018) |
| Braintree Laboratories, Inc. | $28.99 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $689.88 | 47 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($176.78) |
| 2023 | $475.34 | 30 | QOL Medical, LLC ($171.70) |
| 2022 | $165.99 | 9 | ABBVIE INC. ($91.11) |
| 2021 | $260.71 | 11 | Takeda Pharmaceuticals U.S.A., Inc. ($190.90) |
| 2019 | $115.92 | 1 | Boston Scientific Corporation ($115.92) |
| 2018 | $49.27 | 2 | Olympus America Inc. ($36.20) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: LIVER DISEASE | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: Gastroenterology | ||||||
| 09/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.55 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: Gastroenterology | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Gastroenterology | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: Gastroenterology | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Gastroenterology | ||||||
| 07/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 47 | $20,122 | $5,683 |
| 2021 | 3 | 43 | 52 | $12,044 | $4,636 |
Total Patients
72
Total Services
99
Medicare Billing
$10,319
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 31 | $11,322 | $3,419 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,800 | $2,264 | 25.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,648 | $1,830 | 39.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $3,892 | $1,471 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 24 | $3,504 | $1,335 | 38.1% |
About Dr. Elizabeth John, M.D
Dr. Elizabeth John, M.D is a Gastroenterology healthcare provider based in Montville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2016. The National Provider Identifier (NPI) number assigned to this provider is 1346794815.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth John, M.D has received a total of $1,757 in payments from pharmaceutical and medical device companies, with $689.88 received in 2024. These payments were reported across 100 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,747).
As a Medicare-enrolled provider, John has provided services to 72 Medicare beneficiaries, totaling 99 services with total Medicare billing of $10,319. Data is available for 2 years (2021–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Montville, NJ
- Active Since 08/12/2016
- Last Updated 04/06/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346794815
Products in Payments
- XIFAXAN (Drug) $199.35
- Sucraid (Drug) $171.70
- ENTYVIO (Biological) $155.91
- SUCRAID (Drug) $148.30
- MOTEGRITY (Drug) $140.30
- ORISE (Device) $115.92
- TRELEGY ELLIPTA (Drug) $73.69
- STELARA (Biological) $49.12
- HUMIRA (Biological) $48.64
- TRULANCE (Drug) $47.84
- Talicia (Drug) $46.92
- EVIS EXERA (Device) $36.20
- TREMFYA (Drug) $34.20
- LINZESS (Drug) $31.06
- REMICADE (Biological) $30.95
- WaveWriter Alpha Prime 16 (Device) $30.85
- CREON (Drug) $30.34
- SUFLAVE (Drug) $28.99
- ZENPEP (Drug) $28.12
- RESOLUTION CLIP (Device) $27.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.